Ridker PM - Search Results

1

Relation of polymorphism within the C-reactive protein gene and plasma CRP levels.

Suk HJ, Ridker PM, Cook NR, Zee RY. Suk HJ, et al. Among authors: ridker pm. Atherosclerosis. 2005 Jan;178(1):139-45. doi: 10.1016/j.atherosclerosis.2004.07.033. Atherosclerosis. 2005. PMID: 15585211

2

Supplementation with beta-carotene in vivo and in vitro does not inhibit low density lipoprotein oxidation.

Gaziano JM, Hatta A, Flynn M, Johnson EJ, Krinsky NI, Ridker PM, Hennekens CH, Frei B. Gaziano JM, et al. Among authors: ridker pm. Atherosclerosis. 1995 Jan 20;112(2):187-95. doi: 10.1016/0021-9150(94)05414-e. Atherosclerosis. 1995. PMID: 7772078 Clinical Trial.

3

Height and incidence of cardiovascular disease in male physicians.

Hebert PR, Rich-Edwards JW, Manson JE, Ridker PM, Cook NR, O'Connor GT, Buring JE, Hennekens CH. Hebert PR, et al. Among authors: ridker pm. Circulation. 1993 Oct;88(4 Pt 1):1437-43. doi: 10.1161/01.cir.88.4.1437. Circulation. 1993. PMID: 8403290 Clinical Trial.

4

A secondary prevention trial of antioxidant vitamins and cardiovascular disease in women. Rationale, design, and methods. The WACS Research Group.

Manson JE, Gaziano JM, Spelsberg A, Ridker PM, Cook NR, Buring JE, Willett WC, Hennekens CH. Manson JE, et al. Among authors: ridker pm. Ann Epidemiol. 1995 Jul;5(4):261-9. doi: 10.1016/1047-2797(94)00091-7. Ann Epidemiol. 1995. PMID: 8520707 Clinical Trial.

5

Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease.

Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, Cook NR, Belanger C, LaMotte F, Gaziano JM, Ridker PM, Willett W, Peto R. Hennekens CH, et al. Among authors: ridker pm. N Engl J Med. 1996 May 2;334(18):1145-9. doi: 10.1056/NEJM199605023341801. N Engl J Med. 1996. PMID: 8602179 Free article. Clinical Trial.

6

Prospective evaluation of the angiotensin-converting enzyme insertion/deletion polymorphism and the risk of stroke.

Zee RY, Ridker PM, Stampfer MJ, Hennekens CH, Lindpaintner K. Zee RY, et al. Among authors: ridker pm. Circulation. 1999 Jan 26;99(3):340-3. doi: 10.1161/01.cir.99.3.340. Circulation. 1999. PMID: 9918518 Clinical Trial.

7

High levels of plasma C-reactive protein and future risk of age-related cataract.

Schaumberg DA, Ridker PM, Glynn RJ, Christen WG, Dana MR, Hennekens CH. Schaumberg DA, et al. Among authors: ridker pm. Ann Epidemiol. 1999 Apr;9(3):166-71. doi: 10.1016/s1047-2797(98)00049-0. Ann Epidemiol. 1999. PMID: 10192648

8

Hormone replacement therapy and increased plasma concentration of C-reactive protein.

Ridker PM, Hennekens CH, Rifai N, Buring JE, Manson JE. Ridker PM, et al. Circulation. 1999 Aug 17;100(7):713-6. doi: 10.1161/01.cir.100.7.713. Circulation. 1999. PMID: 10449692

9

C-reactive protein, inflammation, and coronary risk.

Morrow DA, Ridker PM. Morrow DA, et al. Among authors: ridker pm. Med Clin North Am. 2000 Jan;84(1):149-61, ix. doi: 10.1016/s0025-7125(05)70211-x. Med Clin North Am. 2000. PMID: 10685132 Review.

10

The role of C-reactive protein in cardiovascular disease risk.

Albert MA, Ridker PM. Albert MA, et al. Among authors: ridker pm. Curr Cardiol Rep. 1999 Jul;1(2):99-104. doi: 10.1007/s11886-999-0066-0. Curr Cardiol Rep. 1999. PMID: 10980827 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,162 results

Search Page

Filters